Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, Du Y, Hou L, Li Z, Ding Z, An S, Huang B, Li L, Tang J, Ju J, Guan H, Song B.
Liu X, et al.
Cancer Lett. 2022 Jul 28;539:215695. doi: 10.1016/j.canlet.2022.215695. Epub 2022 Apr 29.
Cancer Lett. 2022.
PMID: 35501203
No abstract available.